Always inform your medical team about both medications to ensure safe and effective treatment
Study: Patients with type 2 diabetes, having a HbA1c of 7.0 to 10.0% (53 to 86 mmol/mol) and being managed with diet and exercise, with or without metformin were involved in the 26-week, multicentre, double-blind study to ascertain the efficacy and safety of once-daily semaglutide in comparison with once-daily liraglutide and placebo
There is no published evidence of false-positive cross-reactivity and low plausibility given semaglutide's peptide structure
Semaglutide helps people lose weight through various mechanisms, making it an efficient treatment option
Do I have to come into the clinic every week for my injection
However, several factors have led to the rise of compounded versions: Drug Shortages: Ongoing demand has created national shortages, leaving many patients unable to access commercial versions